Nu Skin Enterprises (NUS) Liabilities and Shareholders Equity (2009 - 2026)

Nu Skin Enterprises (NUS) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $1.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 1.05% year-over-year to $1.4 billion; the trailing twelve-month figure through Mar 2026 stood at $5.7 billion (down 6.29% YoY), and the FY2025 full-year result was $1.4 billion, down 4.33% from the prior year.
• Liabilities and Shareholders Equity eased to $1.4 billion in Q1 2026, from $1.4 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.9 billion in Q2 2022 to a low of $1.4 billion in Q1 2026.
• A 5-year average of $1.7 billion and a median of $1.7 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity rose 1.7% in 2023 and fell 20.12% in 2025, its largest moves.
• Tracing NUS's Liabilities and Shareholders Equity over 5 years: stood at $1.8 billion in 2022, then decreased by 0.68% to $1.8 billion in 2023, then fell by 18.78% to $1.5 billion in 2024, then decreased by 4.33% to $1.4 billion in 2025, then declined by 2.03% to $1.4 billion in 2026.
• Business Quant data shows NUS's Liabilities and Shareholders Equity at $1.4 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.4 billion in Q3 2025.